Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
8.67M
-
Shares change
-
+439K
-
Total reported value, excl. options
-
$174M
-
Value change
-
+$8.72M
-
Put/Call ratio
-
0.65
-
Number of buys
-
22
-
Number of sells
-
-23
-
Price
-
$20.14
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q1 2021
63 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q1 2021.
Profound Medical Corp. - Common Shares (PROF) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.67M shares
of 29.9M outstanding shares and own 29.02% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.3M shares), Redmile Group, LLC (846K shares), FIL Ltd (825K shares), LETKO, BROSSEAU & ASSOCIATES INC (820K shares), GAGNON SECURITIES LLC (778K shares), PURA VIDA INVESTMENTS, LLC (772K shares), ROYCE & ASSOCIATES LP (458K shares), Blackcrane Capital, LLC (446K shares), AWM Investment Company, Inc. (349K shares), and Gagnon Advisors, LLC (277K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.